These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11493007)

  • 1. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.
    Groll M; Koguchi Y; Huber R; Kohno J
    J Mol Biol; 2001 Aug; 311(3):543-8. PubMed ID: 11493007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome.
    Groll M; Nazif T; Huber R; Bogyo M
    Chem Biol; 2002 May; 9(5):655-62. PubMed ID: 12031672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
    Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
    J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.
    Yang ZQ; Kwok BH; Lin S; Koldobskiy MA; Crews CM; Danishefsky SJ
    Chembiochem; 2003 Jun; 4(6):508-13. PubMed ID: 12794861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
    Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
    Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gated channel into the proteasome core particle.
    Groll M; Bajorek M; Köhler A; Moroder L; Rubin DM; Huber R; Glickman MH; Finley D
    Nat Struct Biol; 2000 Nov; 7(11):1062-7. PubMed ID: 11062564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigation of proteasome inhibition.
    Ditzel L; Stock D; Löwe J
    Biol Chem; 1997; 378(3-4):239-47. PubMed ID: 9165077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening doors into the proteasome.
    Pickart CM; VanDemark AP
    Nat Struct Biol; 2000 Nov; 7(11):999-1001. PubMed ID: 11062549
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding mode of TMC-95A analogues to eukaryotic 20S proteasome.
    Kaiser M; Groll M; Siciliano C; Assfalg-Machleidt I; Weyher E; Kohno J; Milbradt AG; Renner C; Huber R; Moroder L
    Chembiochem; 2004 Sep; 5(9):1256-66. PubMed ID: 15368577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093.
    Kohno J; Koguchi Y; Nishio M; Nakao K; Kuroda M; Shimizu R; Ohnuki T; Komatsubara S
    J Org Chem; 2000 Feb; 65(4):990-5. PubMed ID: 10814045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
    Kaiser M; Groll M; Renner C; Huber R; Moroder L
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):780-3. PubMed ID: 12491334
    [No Abstract]   [Full Text] [Related]  

  • 12. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome.
    Groll M; Götz M; Kaiser M; Weyher E; Moroder L
    Chem Biol; 2006 Jun; 13(6):607-14. PubMed ID: 16793518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of 20S proteasome from yeast at 2.4 A resolution.
    Groll M; Ditzel L; Löwe J; Stock D; Bochtler M; Bartunik HD; Huber R
    Nature; 1997 Apr; 386(6624):463-71. PubMed ID: 9087403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.
    Furet P; Imbach P; Fürst P; Lang M; Noorani M; Zimmermann J; García-Echeverria C
    Bioorg Med Chem Lett; 2001 May; 11(10):1321-4. PubMed ID: 11392546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A concise, total synthesis of the TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11949-54. PubMed ID: 15163792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: discovery of a new method to generate cis-propenyl amides.
    Lin S; Danishefsky SJ
    Angew Chem Int Ed Engl; 2002 Feb; 41(3):512-5. PubMed ID: 12491396
    [No Abstract]   [Full Text] [Related]  

  • 18. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
    Smith DM; Daniel KG; Wang Z; Guida WC; Chan TH; Dou QP
    Proteins; 2004 Jan; 54(1):58-70. PubMed ID: 14705024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multicatalytic proteinase (prosome, proteasome): comparison of the eukaryotic and archaebacterial enzyme.
    Dahlmann B; Kopp F; Kuehn L; Hegerl R; Pfeifer G; Baumeister W
    Biomed Biochim Acta; 1991; 50(4-6):465-9. PubMed ID: 1801710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory proteins of the proteasome.
    DeMartino GN; Slaughter CA
    Enzyme Protein; 1993; 47(4-6):314-24. PubMed ID: 7697129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.